S
SRPT
Sarepta Therapeutics Inc
15.75
-0.91-5.46%After Hours: 15.79 +0.04 +0.23%19:59 06/05 EDT
OPEN/PREV CLOSE16.59/16.66
TODAY RANGE15.66-16.69
VOL2.74M
MARKET CAP1.66B
52 WEEK RANGE10.42-43.92
AVG VOL (3M)3.08M
% TURNOVER2.60%
TURNOVER--
P/E (TTM)145.03
% RANGE6.18%
EPS(TTM)0.1086
P/E(FORWARD)4.720
P/B1.105
BVPS14.26
DIVIDEND--
P/S0.7521
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.59B
SHARES OUTSTANDING105.58M
NEXT EARNINGS08/04-08/10
FREE FLOAT101.26M
LOT SIZE1
EX-DATE07/12/2012
News
Press Releases
Financial Reports
Profile
Simply Wall St·23h ago
A Look At Sarepta Therapeutics (SRPT) Valuation After New Shelf Registration For Potential Share Offering
TipRanks·2d ago
Sarepta Shareholders Approve 2026 Equity and ESPP Plans
Reuters·05/29 12:12
UPDATE 3-Replimune gets third chance at US approval for skin cancer drug
Simply Wall St·05/26 19:27
A Look At Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness And ELEVIDYS Safety Concerns
NASDAQ·05/22 15:10
KROS Turns to Next Wave of TGF-Beta Muscle Therapies
The Motley Fool·05/20 15:35
My Top 3 Biotech Stocks for May 2026
TipRanks·05/15 12:30
Sarepta price target lowered to $19 from $20 at Evercore ISI
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.